| Transition from acute to chronic pain after surgery P Glare, KR Aubrey, PS Myles The Lancet 393 (10180), 1537-1546, 2019 | 666 | 2019 |
| N[3‐(4′‐fluorophenyl)‐3‐(4′‐phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport KR Aubrey, RJ Vandenberg British journal of pharmacology 134 (7), 1429-1436, 2001 | 113 | 2001 |
| The glycine transporter GlyT2 controls the dynamics of synaptic vesicle refilling in inhibitory spinal cord neurons F Rousseau, KR Aubrey, S Supplisson Journal of Neuroscience 28 (39), 9755-9768, 2008 | 105 | 2008 |
| The transporters GlyT2 and VIAAT cooperate to determine the vesicular glycinergic phenotype KR Aubrey, FM Rossi, R Ruivo, S Alboni, GC Bellenchi, A Le Goff, ... Journal of Neuroscience 27 (23), 6273-6281, 2007 | 101 | 2007 |
| Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine Z Yang, KR Aubrey, I Alroy, RJ Harvey, RJ Vandenberg, JW Lynch Biochemical pharmacology 76 (8), 1014-1023, 2008 | 88 | 2008 |
| N‐Arachidonyl‐glycine inhibits the glycine transporter, GLYT2a AL Wiles, RJ Pearlman, M Rosvall, KR Aubrey, RJ Vandenberg Journal of neurochemistry 99 (3), 781-786, 2006 | 86 | 2006 |
| Glycine transport inhibitors as potential antipsychotic drugs KR Aubrey, RJ Vandenberg Expert Opinion on Therapeutic Targets 5 (4), 507-518, 2001 | 71 | 2001 |
| Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1a RJ Pearlman, KR Aubrey, RJ Vandenberg Journal of neurochemistry 84 (3), 592-601, 2003 | 67 | 2003 |
| Zn2+ inhibits glycine transport by glycine transporter subtype 1b P Ju, KR Aubrey, RJ Vandenberg Journal of Biological Chemistry 279 (22), 22983-22991, 2004 | 61 | 2004 |
| Molecular basis for proton regulation of glycine transport by glycine transporter subtype 1b KR Aubrey, AD Mitrovic, RJ Vandenberg Molecular Pharmacology 58 (1), 129-135, 2000 | 53 | 2000 |
| Dynamics of forward and reverse transport by the glial glycine transporter, glyt1b KR Aubrey, RJ Vandenberg, JD Clements Biophysical journal 89 (3), 1657-1668, 2005 | 41 | 2005 |
| Cytosolic transmitter concentration regulates vesicle cycling at hippocampal GABAergic terminals L Wang, P Tu, L Bonet, KR Aubrey, S Supplisson Neuron 80 (1), 143-158, 2013 | 37 | 2013 |
| Presynaptic control of inhibitory neurotransmitter content in VIAAT containing synaptic vesicles KR Aubrey Neurochemistry international 98, 94-102, 2016 | 32 | 2016 |
| Allosteric modulation of neurotransmitter transporters at excitatory synapses RJ Vandenberg, P Ju, KR Aubrey, RM Ryan, AD Mitrovic European journal of pharmaceutical sciences 23 (1), 1-11, 2004 | 29 | 2004 |
| Heterogeneous signaling at GABA and glycine co-releasing terminals KR Aubrey, S Supplisson Frontiers in synaptic neuroscience 10, 40, 2018 | 28 | 2018 |
| Pharmacologic management of persistent pain in cancer survivors P Glare, K Aubrey, A Gulati, YC Lee, N Moryl, S Overton Drugs 82 (3), 275-291, 2022 | 19 | 2022 |
| Transition from acute to chronic pain: where cells, systems and society meet P Glare, S Overton, K Aubrey Pain Management 10 (6), 421-436, 2020 | 17 | 2020 |
| Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses KR Aubrey, GM Drew, HJ Jeong, BK Lau, CW Vaughan The Journal of Physiology 595 (1), 165-178, 2017 | 16 | 2017 |
| Kappa opioids inhibit the GABA/glycine terminals of rostral ventromedial medulla projections in the superficial dorsal horn of the spinal cord Y Otsu, KR Aubrey The Journal of Physiology 600 (18), 4187-4205, 2022 | 8 | 2022 |
| Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence E Sokolaj, N Assareh, K Anderson, KR Aubrey, CW Vaughan Journal of Neurochemistry, 2023 | 3 | 2023 |
